Pridgen William

Pridgen William serves as a Director at Virios Therapeutics, Inc., a firm focused on developing innovative therapeutics for viral infections. His recent public disclosure activity, as of February 28, 2024, includes a single SEC Form 4 filing, indicating a grant or exercise valued at approximately $1.0K. This disclosure highlights his involvement in the company, with all reported activity concentrated on Virios Therapeutics (VIRI).